fulllogo_transparent_nobuffer Aanastra.png
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
May 02, 2024 06:30 ET | Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
Atari Logo.png
Atari Revives Infogrames as a Publishing Label
April 23, 2024 02:00 ET | Atari Inc.
Atari announces it is reviving Infogrames as a publishing label, starting with purchase of Totally Reliable Delivery Services from tinyBuild LLC.
RNAZ White background cropped.jpg
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15, 2024 09:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
RNAZ White background cropped.jpg
TransCode Therapeutics Reports 2023 Results; Provides Business Update
April 03, 2024 09:10 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Reports 2023 Results; Provides Business Update
RNAZ White background cropped.jpg
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
March 28, 2024 08:30 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
download.png
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
March 25, 2024 08:47 ET | Altamira Therapeutics Ltd
HAMILTON, BERMUDA, March 25, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira’s SemaPhore™ nanoparticlesTargeting safer and accessible mRNA vaccines ...
RNAZ White background cropped.jpg
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
March 11, 2024 09:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
Future Market Insights.png
Polylysine Market Sales to Rise at 10.1% CAGR through 2034 Amid Escalating Demand for Natural Preservatives | Future Market Insights
February 25, 2024 19:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 25, 2024 (GLOBE NEWSWIRE) -- The global polylysine market is estimated to reach a valuation of US$ 728.6 million in 2024. Over the forecast period, global polylysine demand will...
Arrive Partners With AllMart Marketplace to Launch Its Smart Mailbox Solution in Antigua
February 08, 2024 08:30 ET | Arrive Technology Inc.
Autonomous Delivery Testing Expected to Follow in Second Half of 2024 INDIANAPOLIS, IN, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Arrive Technology Inc. ("Arrive"), a technology company...
ahdel_logo.jpg
Ahold Delhaize USA Announces Partnerships with DoorDash
February 07, 2024 09:00 ET | Ahold Delhaize USA
SALISBURY, N.C., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Leading omnichannel grocery retail group Ahold Delhaize USA has announced a new agreement with local commerce platform DoorDash to make an...